Alexis A Mayton, PA-C | |
4755 Ogletown Stanton Rd Ste 2670, Newark, DE 19718-4755 | |
(302) 733-2438 | |
(302) 733-4832 |
Full Name | Alexis A Mayton |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Experience | 16 Years |
Location | 4755 Ogletown Stanton Rd Ste 2670, Newark, Delaware |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053605014 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Christiana Hospital | Newark, DE | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Christiana Care Health Services Inc | 9739097569 | 1248 |
News Archive
Despite dramatic increases in health expenses since 1960, the return on medical spending is high, according to a new study by researchers at Harvard University and the University of Michigan.
Valeant Pharmaceuticals International, Inc. and GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has approved Potiga Tablets, a potassium channel opener, as adjunctive treatment of partial-onset seizures in patients aged 18 years and older.
Children exposed to high levels of polybrominated diphenyl ethers either prenatally or during childhood have poorer attention, fine motor coordination, and intelligence quotients than those exposed to low levels, show results from two studies.
A new scoring method may help predict who is at high risk of serious bleeding after a stroke, according to a study published in the August 2, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Alexis A Mayton, PA-C 4755 Ogletown Stanton Rd Ste 2670, Newark, DE 19718-4755 Ph: (302) 733-2438 | Alexis A Mayton, PA-C 4755 Ogletown Stanton Rd Ste 2670, Newark, DE 19718-4755 Ph: (302) 733-2438 |
News Archive
Despite dramatic increases in health expenses since 1960, the return on medical spending is high, according to a new study by researchers at Harvard University and the University of Michigan.
Valeant Pharmaceuticals International, Inc. and GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has approved Potiga Tablets, a potassium channel opener, as adjunctive treatment of partial-onset seizures in patients aged 18 years and older.
Children exposed to high levels of polybrominated diphenyl ethers either prenatally or during childhood have poorer attention, fine motor coordination, and intelligence quotients than those exposed to low levels, show results from two studies.
A new scoring method may help predict who is at high risk of serious bleeding after a stroke, according to a study published in the August 2, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.
› Verified 1 days ago